KhaledHamawiMDMHA, FASN

PubMed

• 11 citations
  Cost analysis of kidney transplantation in highly sensitized recipients compared to intermittent maintenance hemodialysis
  Ahmed Al-Jedai, Mohammed S. Alsultan, Khalid Almeshari, Khalid Alshaibani, Hazem Elgamal
  Annals of Transplantation. 2012-12-31
• 58 citations
  Outcomes of renal transplantation following bone marrow transplantation.
  Khaled Hamawi, Margarida De Magalhaes-Silverman, J. Andrew Bertolatus
  American Journal of Transplantation. 2003-03-01

Journal Articles

• Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial  
  Amer H, Griffin MD, Stegall MD, Cosio FG, Park WD, Kremers WK, Heilman RL, Mazur MJ, Hamawi K, Larson TS, Kumar R, Am J Transplant, 1/1/2013
• Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease  
  Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K, J Transplant, 1/1/2010
• Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial  
  Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirol..., Transplantation, 1/27/2009

Abstracts/Posters

• Toward a Saudi Calculated PRA: Similarities and Differences with UNOS Calculator.
  Al Zahrani S, Shawhatti A, Liacini A, Borkar M, Tripathi G, Awaji M, Al Saghier M, Housawi A, Hamawi K, AlAttas R, AlOtaibi A, Khan F, Berka N, Journal of Human Immunology, 1/1/2013
• Oral Paricalcitol in Kidney Transplant Recipients Receiving a Corticosteroid-Free Immunosuppressive Regimen: An Open Label Randomized Trial.
  Amer H, Griffin M, Cosio F, Park W, Kremers W, Mazur M, Hamawi K, Larson T, Stegall M, Kumar R, Am J Transplant, 1/1/2012
• Cost analysis of kidney transplantation in highly sensitized recipients compared to intermittent maintenance hemodialysis.
  Al-Jedai A, Alsultan M, Almeshari M, Alshaibani K, Elgamal H, Alkortas D, Khurshid F, Altalhi M, Hamawi K, Ann Transplant, 1/1/2012
• Kidney Transplant Outcomes Using Donors with Diffuse Glomerular Fibrin Thrombi (DGFT).
  Smith M, Heilman R, Chakkera H, Khamash H, Hamawi K, Moss A, Katariya N, Hewitt W, Mulligan D, Reddy K, Am J Transplant, 1/1/2012
• Comparable Patient and Graft Outcomes in Recipients of Expanded Criteria Donor (ECD) and Older Recipients of Standard Criteria Donor (SCD) Kidneys.
  Sando S, Chakkera H, Bodner J, Devarapali Y, Heilman R, Hamawi K, Mulligan D, Moss A, Reddy K, Am J Transplant, 1/1/2012
• Baseline Biopsy Findings and Clinical Outcomes in Recipients of Kidneys from Standard Criteria Donors (SCD) with Acute Kidney Injury (AKI).
  Reddy K, Smith M, Chakkera H, Moss A, Mulligan D, Khamash H, Hewitt W, Katariya N, Hamawi K, Heilman R, Am J Transplant, 1/1/2012
• 1 Year Protocol Biopsy (Bx) Findings in Recipients of Kidneys from Donors with Acute Kidney Injury (AKI) Are Similar to Recipients of Non AKI Donor Kidneys.
  Heilman R, Smith M, Chakkera H, Khamash H, Hamawi K, , Moss A, Mulligan D, Hewitt W, Reddy K, Am J Transplant, 1/1/2012
• Seroconversion Rate and Other Clinical Outcomes in Recipients of Kidneys from Centers for Disease Control (CDC) Risk Deceased Donors.
  Bodner J, Katariya N, Hewitt W, Moss A, Mulligan D, Heilman R, Chakkera H, Hamawi K, Khamash H, Beck G, Reddy K, Am J Transplant, 1/1/2012
• Profile of Inflammatory Markers before and after Kidney Transplantation; Correlation to New-Onset Diabetes Mellitus after Kidney Transplantation.
  Chakkera H, Chang Y, Few J, Pitta T, Heilman R, Reddy K, Moss A, Mulligan D, Khamash H, Hamawi K, Katariya N, Hewitt W, Mandarino L, Am J Transplant, 1/1/2012
• Equivalent measures in insulin resistance at 1 year post transplant among "select" type 2 diabetics receiving SPKTx, type 1 diabetics receiving SPKTx and non diabetics...
  Chakkera H, Bodner J, Patel S, Lambert R, Heilman R, Mulligan D, Moss A, Hamawi K, Petersen A, Reddy K, Am J Transplant, 1/1/2011
• Pre-transplant risk score predicts development of new onset diabetes mellitus after kidney transplantation.
  Chakkera H, Dueck A, Weil E, Cook C, Swanson C, Heilman R, Reddy K, Hamawi K, Moss A, Mulligan D, Knowler W, Am J Transplant, 1/1/2011
• Improved quality of life post kidney transplantation.
  Chakkera H, Wu Q, Pitta T, Heilman R, Reddy K, Mulligan D, Moss A, Hamawi K, Dueck A, Am J Transplant, 1/1/2011
• Comparison of 1-yr protocol biopsy findings in kidney transplant recipients on rapid steroid withdrawal (RSW) getting induction with either alemtuzumab (alem), rabbit-...
  Heilman R, Nijim S, Chakkera H, Hamawi K, Williams J, Moss A, Mulligan D, Reddy KS, Am J Transplant, 1/1/2011
• Induction with either alemtuzumab, r-ATG or basiliximab associated with similar outcomes in kidney transplant recipients on rapid steroid withdrawal.
  Reddy KS, Nijim S, Chakker H, Hamawi K, Williams J, Moss A, Mulligan D, Heilman R, Am J Transplant, 1/1/2011
• Subclinical acute rejection is associated with inferior graft survival in kidney transplant recipients on rapid steroid withdrawal.
  Heilman RL, Devarapalli Y, Chakkera H, Mekeel K, Moss A, Williams J, Hamawi K, Mazur M, Mulligan D, Reddy KS, Am J Transplant, 1/1/2010
• Influence of modest hypertension on the 1 year protocol biopsy (chronic interstitial fibrosis and tubular atrophy scores) among kidney transplant recipients on rapid s...
  Chakkera H, Devarapalli Y, Mulligan D, Reddy K, Moss A, Mekeel K, Mazur M, Hamawi K, Heilman R, Am J Transplant, 1/1/2010
• Predictive risk of pre-transplant fasting glucose on the development of new onset diabetes after kidney transplantation.
  Chakkera H, Devarapalli Y, Weil EJ, Mazur MJ, Hamawi K, Reddy KS, Mulligan DC, Moss AA, Mekeel KL, Heilman RL, Am J Transplant, 1/1/2010
• Comparison of insulin resistance post transplant among type 2 diabetics receiving SPK transplant to type 1 diabetics receiving SPK and to non-diabetics receiving kidne...
  Chakkera H, Bodner J, Heilman RL, Mulligan DC, Mazur MJ, Moss AA, Mekeel KL, Hamawi K, Reddy KS, Am J Transplant, 1/1/2010
• Magnitude and consequences of de novo hyperglycemia immediately post kidney transplantation (FC052).
  Chakkera HA, Devarapalli Y, Heilman RL, Mazur MJ, Hamawi K, Mulligan D, Reddy K, Moss A, Mekeel K, Cook C, J Am Soc Nephrol, 1/1/2009
• Alemtuzumab with rapid steroid taper in simultaneous kidney pancreas transplantation: Comparison to induction with antiyhymocyte globulin.
  Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D, Xenotransplantation, 1/1/2009
• Induction with single dose alemtuzumab subcutaneously in simultaneous kidney pancreas (SPK) transplantation.
  Post DJ, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, MeKeel KL, Moss AA, Reddy KS, Xenotransplantation, 1/1/2009
• Simultaneous kidney pancreas transplantation in select patients with type 2 diabetes mellitus having positive C-peptide and negative GAD-65 antibody.
  Chakkera H, Bodner J, Heilman R, Mazur M, Mulligan D, Moss A, Hamawi K, Mekeel K, Reddy K, Xenotransplantation, 1/1/2009
• Timing of resolution of hyperparathyroidism (HPTH) after kidney transplantation (KT) - either early or never (PO976).
  Sexton DJ, Heilman R, Chakkera H, Hamawi K, Mulligan D, Moss A, Mekeel K, Reddy K, Petrides S, Mazur MJ, J Am Soc Nephrol, 1/1/2009
• Pancreas transplantation using HTK preservative solution: is it a cautionary tale?
  Reddy KS, Moss A, Mekeel K, Mazur M, Heilman R, Chakkera H, Hamawi K, Devarapalli Y, Mulligan D, Am J Transplant, 1/1/2009
• Outcomes of simultaneous kidney pancreas (SPK) transplant recipients with alemtuzumab induction and steroid avoidance immunosuppression: comparison of intravenous vs. ...
  Post DJ, Mazur MJ, Chakkera HA, Heilman RL, Hamawi K, Mulligan DC, MeKeel KL, Moss AA, Reddy KS, Am J Transplant, 1/1/2009
• Join now to see all

Lectures

• "Malignancy Post Kidney Transplantation" 
  King Fahad Hospital - Al Hassa, Saudi Arabia - 1/1/2013
• "International Guidelines and Standards for Workup and Assessment of the Kidney Donor" 
  Abu Dhabi, United Arab Emirates - 1/1/2012
• "Virtual Cross Match and cPRA, Impact on Utilization and Allocation" 
  Abu Dhabi, United Arab Emirates - 1/1/2012
• "Experience with Kidney Transplantation in Highly Sensitized Patients" 
  Dammam, Saudi Arabia - 1/1/2010
• "Kidney Transplantation in Highly Sensitized Patients" 
  Corpus Christi, TX - 1/1/2010
• "Clinical Pathology Case" 
  Jeddah, Saudi Arabia - 1/1/2007
• "Introduction to Solid Organ Transplantation" 
  King Faisal Specialist Hospital & Research Center - 1/1/2006
• Non-infectious Post-Transplant complications. 
  King Faisal Specialist Hospital & Research Center - 1/1/2006
• "Current Status of Organ Donation in Saudi Arabia" 
  King Faisal Specialist Hospital & Research Center - 1/1/2005
• Post-transplant complications. 
  King Abdulaziz University Medical School - 1/1/2004
• Pre-transplant evaluation for potential recipients. 
  1/1/2003
• Join now to see all

Other

• Metabolic Acidosis. 
  Thomas C, Hamawi K, Nephrology Online Textbook
  1/1/2000